Base editing shows promise for treating sickle cell disease and beta thalassemia

FHS
July 3, 2023
4:12 pm

Gene therapy that alters hemoglobin genes may be an answer to curing sickle cell disease (SCD) and beta thalassemia.

Medicare Advantage plan’s quality ratings were incorrectly calculated by government, judge rules

The federal government inappropriately lowered the 2024 Medicare Advantage star ratings of SCAN Health Plan, which led to the health insurance company in California losing

June 4, 2024

The competitive edge: Unlocking the full potential of autoinjectors through comprehensive in-house manufacturing – Pharmaceutical Technology

SHL Medical’s in-house automation equipment program enables increased flexibility and scalability for autoinjector testing, assembly, and final assembly. Credit: SHL Medical. The drug delivery device

September 26, 2023

Big Pharma Enters The Psychedelic Space Beyond Partnerships Otsuka Acquires Mindset Pharma

Canadian next-generation psychedelics developer Mindset Pharma MSSTF has entered into a definitive agreement by which Otsuka America Inc., the U.S. arm of Otsuka Pharmaceutical Co., would acquire all its outstanding

August 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.